LI
ACAD icon

Leap Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Leap Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$630K Buy
+13,000
New +$624K 0.41% 74
2020
Q1 		– Sell
-6,000
Closed -$257K – 349
2019
Q4 		$257K Sell
6,000
-9,800
-62% -$426K 0.12% 274
2019
Q3 		$569K Buy
+15,800
New +$479K 0.28% 114

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Leap Investments's ACAD Position: Q2 2020 in Review

Leap Investments opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2020: 13,000 shares worth $630K. The stake represents 0.41% of the portfolio and ranks #74 among its holdings. This is a return to the name: Leap Investments previously reported a position in ACAD as recently as Q4 2019.

Leap Investments first reported a position in ACAD in Q3 2019 and has held it in 3 quarters since. 297 funds tracked by Wall St. Rank hold ACAD as of Q2 2020.

  • Leap Investments held 13,000 shares of Acadia Pharmaceuticals worth $630K as of Q2 2020.
  • Acadia Pharmaceuticals was a new Leap Investments position in Q2 2020.
  • Acadia Pharmaceuticals made up 0.41% of Leap Investments's portfolio in Q2 2020, its #74 holding.
  • Leap Investments first reported a position in Acadia Pharmaceuticals in Q3 2019 and has held it in 3 quarters since.
  • 297 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.